Neurogenic Inflammation and cardiac dysfunction due to hypomagnesemia

American Journal of the Medical Sciences

Volumn 338, Issue 1, 2009, Pages 22-27

  Kramer, Jay H ^a   Spurney, Christopher ^b   Iantorno, Micaela ^b   Tziros, Constantine ^a   Mak, I Tong ^a   Tejero Taldo, M Isabel ^a   Chmielinska, Joanna J ^a   Komarov, Andrei M ^a   Weglicki, William B ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

Antioxidants; Cardiac dysfunction; Cardiac inflammation; Dietary Mg deficiency; Hypomagnesemia; Ischemia reperfusion injury; Neurokinin 1 receptor antagonists; NMDA receptor blocker; Oxidative and nitrosative stress; Substance P

Indexed keywords

2 BENZHYDRYL 3 (2 IODOBENZYLAMINO)QUINUCLIDINE; 2 BENZHYDRYL 3 (2 METHOXYBENZYLAMINO) 1 AZABICYCLO[2.2.2]OCTANE; ALPHA TOCOPHEROL; CD11B ANTIGEN; CD14 ANTIGEN; DEXPROPRANOLOL; DIZOCILPINE; EPICAPTOPRIL; GAMMA INTERFERON; HISTAMINE; HYDROXYL RADICAL; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MAGNESIUM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROKININ 1 RECEPTOR; NITRIC OXIDE; PEROXYNITRITE; PROBUCOL; PROSTAGLANDIN E2; SUBSTANCE P; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; NEUROPEPTIDE;

APOPTOSIS; CARDITIS; CELL INFILTRATION; CONFERENCE PAPER; DIET RESTRICTION; DIETARY INTAKE; DISEASE MODEL; DISEASE PREDISPOSITION; ECHOCARDIOGRAPHY; ENDOTHELIUM CELL; ENDOTOXEMIA; ENTERITIS; ENZYME SYNTHESIS; HEART CONTRACTION; HEART DISEASE; HEART INJURY; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEART PROTECTION; HEART STRESS; HEART WORK; HYPOMAGNESEMIA; INFLAMMATORY CELL; INTESTINE MUCOSA PERMEABILITY; LOW DRUG DOSE; MAGNESIUM DEFICIENCY; NEUROGENIC INFLAMMATION; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; RECEPTOR BLOCKING; REPERFUSION INJURY; ANIMAL; CARDIOMYOPATHY; DIET; HUMAN; METABOLISM; RAT; REVIEW;

ANIMALS; CARDIOMYOPATHIES; DIET; ENDOTOXEMIA; HUMANS; MAGNESIUM DEFICIENCY; MYOCARDIAL REPERFUSION INJURY; NEUROGENIC INFLAMMATION; NEUROPEPTIDES; OXIDATIVE STRESS; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, NEUROKININ-1;

EID: 68849118038     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181aaee4d     Document Type: Conference Paper

References (59)

1. Seelig M. Cardiovascular consequences of magnesium deficiency and loss: Pathogenesis, prevalence and manifestations-magnesium and chloride loss in refractory potassium repletion. Am J Cardiol 1989;63: 4G-21G.
2. Altura BM, Altura BT. New perspective on the role of Mg in the pathophysiology of the cardiovascular system. I. Clinical aspects. Magnesium 1985;4:226-244
3. Dubey A, Solomon R. Magnesium, myocardial ischaemia and arrhythmias: The role of magnesium in myocardial infarction. Drugs 1989;37: 1-7.
4. Kotamraju S, Chitambar CR, Kalivendi SV, et al. Transferrin receptor-dependent iron uptake is responsible for doxorubicin-mediated apoptosis in endothelial cells: Role of oxidant-induced iron signaling in apoptosis. J Biol Chem 2002;277:17179-17187
5. Vormann J, Fischer G, Classen H-G, et al. Influence of decreased and increased magnesium supply on the cardiotoxic effects of epinephrine in rats. Arzneimittelforschung 1983;33:205-210
6. Duquaine D, Hirsch GA, Chakrabarti A, et al. Rapid-onset endothelial dysfunction with adriamycin: Evidence for a dysfunctional nitric oxide synthase. Vasc Med 2003;8:101-107
7. Leary WP. Content of magnesium in drinking water and deaths from ischaemic heart disease in white South Africans. Magnesium 1986;5: 150-153
8. Sharma R, Bolger AP, Li W, et al. Elevated circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congenital heart disease. Am J Cardiol 2003;92:188-193
9. Weglicki WB, Mak IT, Stafford RE, et al. Neurogenic peptides and the cardiomyopathy of magnesium-deficiency: Effects of substance P-receptor inhibition. Mol Cell Biochem 1994;130:103-109
10. Weglicki WB, Mak IT, Kramer JH, et al. Role of free radicals and substance P in magnesium deficiency. Cardiovasc Res 1996;31:677-682
11. Weglicki WB, Dickens BF, Wagner TL, et al. Immunoregulation by neuropeptides in magnesium deficiency: Ex vivo effect of enhanced substance P production on circulating T lymphocytes from Mg-deficient mice. Magnesium Res 1996;9:3-11.
12. Vormann J, Gunther T, Hollriegl V, et al. Pathobiochemical effects of graded magnesium deficiency in rats. In: Advances in magnesium research; 1997. p. 422-434
13. Punsar S, Karvonen MJ. Drinking water quality and sudden death: Observations from west and east Finland. J Am Coll Nutr 1985;4:195-206.
14. Chang C, Varghese J, Downey J, et al. Magnesium deficiency and myocardial infarct size in the dog. J Am Coll Cardiol 1985;5:280-289
15. Rector WJ Jr, DeWood MA, Williams RV, et al. Serum magnesium and copper levels in myocardial infarction. Am J Med Sci 1981;281: 25-29
16. Ahmad A, Bloom S. Sodium pump and calcium channel modulation of Mg-deficiency cardiomyopathy. Am J Cardiovasc Pathol 1989;2:277-283
17. Weglicki WB, Freedman AM, Bloom S, et al. Antioxidants and the cardiomyopathy of Mg-deficiency. Am J Cardiovasc Pathol 1992;4: 210-215
18. ItokawaY. Tissue minerals of magnesium-deficient rats with thiamine deficiency and excess. Magnesium 1987;6:48-54.
19. Heggtveit HA, Herman L, Mishra RK. Cardiac necrosis and calcification in experimental magnesium deficiency. A light and electron microscopic study. Am J Pathol 1964;45:757-782
20. Borchgrevink PC, Jynge P. Acquired magnesium deficiency and myocardial tolerance to ischemia. J Am Coll Nutr 1987;6:355-363 (Pubitemid 18201297)
21. Kramer JH, Mišík V, Weglicki WB. Magnesium-deficiency potentiates free radical production associated with post-ischemic injury to rat hearts: Vitamin E affords protection. Free Rad Biol Med 1994;16:713-723
22. Weglicki WB, Phillips TM, Freedman AM, et al. Magnesiumdeficiency elevates circulating levels of inflammatory cytokines and endothelin. Mol Cell Biochem 1992;110:169-173
23. Weglicki WB, Phillips TM, Mak IT, et al. Cytokine, neuropeptides, and reperfusion injury during magnesium-deficiency. Ann N Y Acad Sci 1994;723:246-257
24. Weglicki WB, Phillips TM, Cassidy MM, et al. Pro-oxidant stress in Mg-deficiency: Role of neuropeptides and cytokines. In: Davies KJA, Ursini F, editors. The oxygen paradox. Padova, Italy: Cleop University Press; 1995. p. 773-782
25. Weglicki WB, Phillips TM. Pathobiology of magnesium deficiency: A cytokine/neurogenic inflammation hypothesis. Am J Physiol 1992;263: R734-R737.
26. Weglicki WB, Mak IT, Phillips TM. Blockade of cardiac inflammation in Mg2- deficiency by substance P receptor inhibition. Circ Res 1994;74:1009-1013
27. Mantyh PW. Substance P and the inflammatory and immune response. Ann N Y Acad Sci 1991;632:263-271
28. Bost KL, Pascual DW. Substance P: A late-acting B lymphocyte differentiation cofactor. Am J Physiol Cell Physiol 1992;262:C537-C545.
29. Weglicki WB, Mak IT, Phillips TM. Blockade of cardiac inflammation in Mg-deficiency by substance P receptor inhibition. Circ Res 1994;24:1009-1013
30. Weglicki WB, Dickens BF, Mak IT, et al. Role of tissue and circulating substance P in cardiovascular injury associated with Mgdeficiency. In: Dhalla NS, Singal PK, Takeda N, et al, editors. Pathophysiology of heart failure. Boston (MA): Kluwer Academic Publishers; 1995. p. 9-190.
31. Furness JB, Costa M, Papka RE, et al. Neuropeptides contained in peripheral cardiovascular nerves. Clin Exp Hypertens A 1984;6:91-106.
32. Kramer JH, Phillips TM, Weglicki WB. Magnesium-deficiency enhanced postischemic myocardial injury is reduced by substance P receptor blockade. J Mol Cell Cardiol 1997;29:97-110.
33. Mak IT, Kramer JH, Weglicki WB. Suppression of neutrophil and endothelial activation by substance P receptor blockade in the Mgdeficient rat. Magnes Res 2003;16:91-97
34. Weglicki WB, Kramer JH, Mak IT. The role of antioxidant drugs in oxidative injury of cardiovascular tissue. In: Oxidative stress and antioxidants in heart failure. Heart Fail Rev 1999;4:183-192.
35. Kramer JH, Spurney C, Mak I-T, et al. Echocardiography reveals progressive cardiac dysfunction in Mg-deficient rats. J Investigative Med 2009;57:318.
36. McIntosh TK. Novel pharmacologic therapies in the treatment of experimental traumatic brain injury: A review. J Neurotrauma 1993;10: 215-261
37. Tejero-Taldo MI, Chmielinska JJ, Gonzalez G, et al. N-Methyl-Daspartate receptor blockade inhibits cardiac inflammation in the Mgdeficient rat. J Pharmacol Exp Ther 2004;311:8-13.
38. Tejero-Taldo MI, Chmielinska JJ, Weglicki WB. Chronic dietary Mg2- deficiency induces cardiac apoptosis in the rat heart. Magnes Res 2007;20:208-212
39. Kramer JH, Mak IT, Dickens BF, et al. Modulation of circulating substance P in Mg-deficient (MgD) rats by NMDA receptor and neutral endopeptidase inhibitors-abstract. FASEB J 2007;21(6, pt. II):A1066.
40. Leeman SE. Substance P and neurotensin: Discovery, isolation, chemical characterization and physiological studies. J Exp Biol 1980;89: 193-200.
41. Mak IT, Kramer JH, Dickens BF, et al. NMDA receptor blockade attenuates neutrophil activation and systemic oxidative stress induced by Mg-deficiency in rats-abstract-. FASEB J 2007;21(5, pt. I):A45.
42. DeRose V, Robbins RA, Snider RM, et al. Substance P increases neutrophil adhesion to bronchial epithelial cells. J Immunol 1994;152: 339-1345.
43. Kubes P, Kanwar S, Niu X-F, et al. Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J 1993;7:1293-1299
44. Brewster DR, Goetzl EJ. Specific stimulation of human T lymphocytes by substance P. J Immunol 1983;131:1613-1615
45. Hartung H-P, Toyka KV. Activation of macrophages by substance P induction of oxidative burst and thromboxane release. Eur J Pharmacol 1983;89:301-305
46. Hafstrom I, Gyllenhammar H, Palmblad J, et al. Substance P activates and modulates neutrophil oxidative metabolism and aggregation. J Rheumatol 1989;16:1033-1037
47. Persson MG, Hedqvist P, Gustafsson LE. Nerve-induced tachykininmediated vasodilation in skeletal muscle is dependent on nitric oxide formation. Eur J Pharmacol 1991;205:295-301.
48. Mak IT, Dickens BF, Komarov AM, et al. Activation of the neutrophil and loss of plasma glutathione during Mg-deficiency-modulation effect by NOS inhibition. Mol Cell Biochem 1997;176:35-39
49. Tejero-Taldo MI, Kramer JH, Mak I-T, et al. The nerve-heart connection in the pro-oxidant response to Mg-deficiency. Heart Fail Rev 2006;11:35-44.
50. Tejero-Taldo MI, Chmielinska JJ, Weglicki WB. Magnesium deficiency stimulates angiogenesis in the rat heart-abstract. J Mol Cell Cardiol 2004;36:631.
51. Zhou M, Arthur AJ, Ba ZF, et al. The small intestine plays an important role in upregulating CGRP during sepsis. Am J Physiol Regul Integr Comp Physiol 2001;280:R382-R388.
52. Scudamore CL, Pennington AM, Thornton E, et al. Basal secretion and anaphylactic release of rat mast cell protease II (RMCP-II) from ex vivo perfused rat jejunum: Translocation of RMCP-II into the gut lumen and its relation to mucosal histology. Gut 1995;37:235-241
53. Scanlan BJ, Kim SY, Tuft B, et al. Intestinal inflammation caused by magnesium deficiency alters basal and oxidative stress-induced intestinal function. Mol Cell Biochem 2007;306:59-69.
54. Baumgarten G, Knuefermann P, Nozaki N, et al. In vivo expression of proinflammatory mediators in the adult heart after endotoxin administration: The role of toll-like receptor-4. J Infect Dis 2001;183:1617-1624
55. Comstock KL, Krown KA, Page MT, et al. LPS-induced TNF-alpha release from and apoptosis in rat cardiomyocytes: Obligatory role for CD14 in mediating the LPS response. J Mol Cell Cardiol 1998;30: 2761-2775
56. Kramer JH, Mak IT, Phillips TM, et al. Dietary Mg-intake influence circulating pro-inflammatory neuropeptide levels and loss of myocardial tolerance to postischemic stress. Exp Biol Med 2003;228:665-673
57. Soma M, Cunnane SC, Horrobin DF, et al. Effects of low magnesium diet on the vascular prostaglandin and fatty acid metabolism in rats. Prostaglandins 1988;36:431-441
58. Kraeuter SL, Schwartz R. Blood and mast cell histamine levels in magnesium-deficient rats. J Nutr 1980;110:851-858
59. Deheinzelin D, Negri EM, Tucci MR, et al. Hypomagnesemia in critically ill cancer patients: A prospective study of predictive factors. Braz J Med Biol Res 2000;33:1443-1448